NEXT

New Jersey Law Journal

$100M Settlement: PharMerica Corp. Agrees to 9-Figure Deal

"We believed in our case, and that is why we committed so many resources to litigating it. And in the end, you know, I believe that we got a very excellent result," said Sherrie R. Savett of Berger Montague, who represented the plaintiff.
4 minute read

New Jersey Law Journal

Personal Injury, Product Liability Suit Against AbbVie's CoolSculpting Returns to State Court

"The complaint generally alleges the elements for holding a medical provider strictly liable under a defective design theory, and AbbVie has not cited ... to a single case which addresses the pleading requirements in state court," wrote U.S. District Judge Robert Kirsch for the District of New Jersey. "In order for a court to find fraudulent joinder, 'it must be impossible for a state court to find that a plaintiff has stated a valid cause of action.'"
4 minute read

New Jersey Law Journal

Saul Ewing Attorneys to Defend AI Pharma-Tech Company in Securities Class Action

Saul Ewing's Sarah A. Sullivan and Alexander Lee Callo in Newark have recently entered appearances on behalf of an artificial intelligence-driven pharma-tech company sued in a pending securities class action.
4 minute read

Law.com

'Endlessly Delay': Court Allows Generic Drug Company's Implied Breach of Duty to Proceed Against Partner

A federal judge in Illinois is allowing a drug company's lawsuit over the untimely development of drug medication to continue against pharmaceutical companies it had partnered with to develop medications.
4 minute read

Connecticut Law Tribune

Boehringer Ingelheim Pharmaceuticals Loses Challenge to Inflation Reduction Act

"We are disappointed by this ruling and what it means for biopharmaceutical innovation," the company said. "Boehringer Ingelheim shares the goal of ensuring our medicines are affordable and available to people who need them. However, we remain concerned about the detrimental and limiting effects the IRA and its 'negotiation' program will have on the future of innovation for the patients we serve."
3 minute read

New York Law Journal

NY Ready to Reopen Claim Against Purdue Pharma, If 60-Day Negotiating Window Closes Without Accord

The developments follow the U.S. Supreme Court's 5-4 ruling on June 27 that rejected a nationwide settlement.
4 minute read

National Law Journal

PBMs' Actions Might Increase Drug Prices, Drive Out Independent Pharmacies, FTC Reports

The agency voted 4-1 to issue the report on pharmacy benefit managers, with Republican Commissioner Melissa Holyoak being the sole dissenter.
6 minute read

The Legal Intelligencer

Phila. Zantac Plaintiffs Move for Judge to Recuse Over Alleged Conflict

"While I offer no opinion as to whether Judge Roberts harbors any actual bias in favor of pharmaceutical companies, specifically including GSK, there are many reasons why Judge Roberts' ability to rule impartially in this case may reasonably be questioned," Stengel wrote.
3 minute read

Delaware Business Court Insider

Novo Nordisk Seeks Patent Litigation Barrier to Ozempic Generic

The Ozempic manufacturer, represented in both cases by Fenwick & West, filed one complaint on Wednesday in the District of Delaware, then filed a nearly identical one in the Northern District of West Virginia.
2 minute read

Law.com

Judge Denies Wholesalers' Class Certification in RICO Suit Against EpiPen Manufacturer Mylan

U.S. District Judge Eric C. Tostrud for the District of Minnesota determined that the plaintiffs failed to affirmatively demonstrate the class was so numerous and joinder of all members is impracticable under Rule 23(a)(1), that the representative parties will adequately protect the interests of the class under Rule 23(a)(4), or that questions of law or fact common to class members predominate over any questions affecting only individual members under Rule 23(b)(3).
5 minute read

Resources

  • Yearly Roundup: Strategic Insights for Law Firm Decision Making

    Brought to you by CARET Legal

    Download Now

  • Lex Machina Contracts: Commercial Litigation Report 2024

    Brought to you by LexisNexis®

    Download Now

  • White Collar Investigation Practice: Global Expertise in Complex Investigations

    Brought to you by HaystackID

    Download Now

  • Criminal Division's Evaluation of Corporate Compliance Programs: September 2024 Updates Review

    Brought to you by NAVEX Global

    Download Now